Clinical Trial Update: Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a study evaluating novel therapeutics in newly diagnosed high-risk acute myeloid leukemia; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia Arising From Previous Myelodysplastic Myeloproliferative Neoplasm
• Acute Myeloid Leukemia Myelodysplasia-related
• Acute Myeloid Leukemia Post Cytotoxic Therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm | Phase 2 | Status: RECRUITING